References
- Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009;360:2277-2288. https://doi.org/10.1056/NEJMoa0808145
- Krishnan K, Pandolfino JE, Kahrilas PJ, et al. Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology 2012;143:576-581. https://doi.org/10.1053/j.gastro.2012.05.005
- Tsoi EH, Cameron G, Williams R, et al. Factors that predict a poor response to radiofrequency ablation for Barrett's oesophagus with dysplasia. ANZ J Surg 2020;90:272-276. https://doi.org/10.1111/ans.15687
- Bulsiewicz WJ, Kim HP, Dellon ES, et al. Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus. Clin Gastroenterol Hepatol 2013;11:636-642. https://doi.org/10.1016/j.cgh.2012.10.028
- Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett's esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013;11:1245-1255. https://doi.org/10.1016/j.cgh.2013.03.039
- Welsch L, May A, Blasberg T, et al. Bile acid sequestrants in poor healing after endoscopic therapy of Barrett's esophagus. Clin Endosc 2023;56:194-202.
- Huo X, Juergens S, Zhang X, et al. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells. Am J Physiol Gastrointest Liver Physiol 2011;301:G278-G286. https://doi.org/10.1152/ajpgi.00092.2011
- Sun D, Wang X, Gai Z, et al. Bile acids but not acidic acids induce Barrett's esophagus. Int J Clin Exp Pathol 2015;8:1384-1392.
- McQuaid KR, Laine L, Fennerty MB, et al. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther 2011;34:146-165. https://doi.org/10.1111/j.1365-2036.2011.04709.x